Stocks to sell

A bit of positive news included in Carnival’s (NYSE:CCL) second-quarter results lifted CCL  stock in late September. But even as the world appears on track to get “back to normal,” you may not want to buy Carnival’s shares at its present levels. There’s a good chance that the cruise line operator’s results will fully bounce
0 Comments
A year ago, electric vehicles (EVs) were a promising sector for investors. But in 2021, that all changed. Sponsors of special purpose acquisition companies (SPACs) flooded the market with new EV stock investments. Some of these, like Lucid Motors (NASDAQ:LCID), have worked out pretty well. Most, however, have been terrible for investors. Unfortunately, Lordstown Motors
0 Comments
With the seemingly worsening crisis of property developer China Evergrande (OTCMKTS:EGRNF), it may be time for investors to at least consider reducing exposure to companies tied to the world’s second-largest economy. Late last week, the Wall Street Journal reported that Evergrande failed to make a scheduled interest payment last Thursday, sparking concerns about a mass
0 Comments
For AMC (NYSE:AMC) stock, the easing of Americans’ fears about the pandemic, along with the approaching end of the outbreak, is certainly very positive news. Source: viewimage / Shutterstock.com Nonetheless, the movie theater owner is facing multiple other tough problems. First of all, it faces continued competition from streaming services. Second, AMC has significant debt
0 Comments
Plug Power (NASDAQ:PLUG), the hydrogen fuel cell company, was somehow able to raise more than $3.4 billion in two different tranches in January and February 2021. The company sold $1.6 billion of PLUG stock at $29.29 in February to a subsidiary of SK Holdings, the third-largest conglomerate in South Korea. Source: Shutterstock Additionally, it managed
0 Comments
Any investment in Ocugen (NASDAQ:OCGN) stock is based on hope. That hope involves the FDA approving the Covid-19 vaccine known as Covaxin.    Source: shutterstock.com/PhotobyTawat Over the last six months or so, the company has repeatedly suggested that such an approval was imminent. On Feb. 2,  Ocugen announced an agreement with the Indian drug maker
0 Comments
Just one month ago, sentiment surrounding mobile e-commerce company ContextLogic (NASDAQ:WISH) was positive. Seven analysts considered WISH stock a “buy” and four others rated the stock a “hold.” But these days, sentiment has darkened considerably. Currently, only three analysts have a “buy” rating on WISH stock, with six saying it’s a “hold” and two more
0 Comments